Securisyn partners with Meddux Development to support new Product Pipeline
August 12, 2019 Under this partnership, Securisyn will work with Meddux to help generate near-term concept prototypes for the purpose of gaining user feedback and examining product viability around Securisyn’s proprietary integrated restraint system technology and related design concepts.
Securisyn joins Coalition for Unplanned Extubation Awareness and Prevention
July 3, 2019 The coalition’s collective goal is to raise awareness about UE and work with hospitals to implement standardized policies and procedures, and begin tracking and implementing quality measures.
Securisyn joins Mayo Clinic and ASU's MedTech Accelerator
April 24, 2019 The accelerator kicks off with an immersion program April 22–May 3 at Mayo Clinic's Arizona campus. Attending this event are Co-Founder Elyse Blazevich and President and CEO, Mark Bruning.
Securisyn Medical Joins the Catalyst HTI Ecosystem
March 20, 2019 Securisyn Medical, proudly announces that we have joined the Catalyst HTI ecosystem in Denver, Colorado.
Securisyn Medical Submits 510(K) to U.S. FDA for SolidAIRity™ III Airway Stabilization System
March 12, 2019 Securisyn Medical, LLC, today announced the 510(k) Premarket Notification submission to the U.S. Food and Drug Administration for its proprietary SolidAIRity™ III Airway Stabilization System.
Securisyn Medical Awarded Air Force Contract for Innovation
March 8, 2019 Securisyn Medical, LLC, announced today that the United States Air Force (USAF) has awarded the Company a $158,000 Small Business Innovation Research (SBIR) Phase I contract through the U.S. Air Force Inaugural Pitch Day competition in New York City.
Securisyn Medical selected to attend Inaugural US Air Force Pitch Day
February 22, 2019 Securisyn Medical, LLC, today announced they are one of 59 companies selected out of hundreds nationally to present its novel technology in support of the Company’s Air Force Small Business Innovation Research Phase I proposal at the Inaugural Air Force Pitch Day event on March 6-7, 2019 in New York City.
Securisyn Medical awarded $250,000 Early Stage Capital and Retention Grant
November 19, 2018 The Colorado Office of Economic Development and International Trade (OEDIT) has awarded Securisyn Medical a $250,000 Early Stage Capital and Retention Grant to accelerate required FDA 510(k) testing and post-clearance clinical trials for the Company’s patented airway stabilization system, SolidAIRity™.